Stock Screening

Find the best potential employer the same way you would find a profitable stock.  Strong leading indicators, such as Earnings per Share, Earnings Growth Rate, and Return on Equity point to a company in the hiring mode.

Selected terms:

Earnings per Share (EPS)
Total earnings divided by the number of shares outstanding. Companies often use a weighted average of outstanding stock over the reporting term.
earnings
Revenues minus cost of sales, operating expenses, and taxes, over a given period of time.
debt/equity ratio
A measure of a company's leverage, calculated by dividing long-term debt by common shareholders' equity, usually using the data from the previous fiscal year.
yield
The annual rate of return on an investment, expressed as a percentage. For bonds and notes, it is the coupon rate divided by the market price. For securities, it is the annual dividends divided by the purchase price; here, also called dividend yield or current yield.
market value
A security's last reported sale price (if on an exchange) or its current bid and ask prices (if over-the-counter); i.e. the price as determined dynamically by buyers and sellers in an open market. also called market price.

Search parameters: 
150%+  increase in Earnings per Share last Quarter AND a growth rate over 50% for the past 5 years.

Company Name Last
close
P/E Yield Return on Equity Debt to Equity Ratio % Chg EPS Last Qtr Earn. Growth Rate Market
Value (MM)
GRUPO RADIO CENTRO 5.35 2.0 48.3 19.4 0.23 246.4 62.5 110
TARO PHARMACEUTICAL INDS 37.00 59.7 0.0 20.0 0.76 166.7 53.8 999
Company Name Last
close
P/E Yield Return on Equity Debt to Equity Ratio % Chg EPS Last Qtr Earn. Growth Rate Market
Value (MM)

Back

Detailed Company Information:

TARO PHARMACEUTICAL INDS
14 Haiktor Street
Haifa Bay, IS 26110
Ticker: TARO
Exchange: NASD
Phone: (729) 955-7942
Fiscal Yr Month: DEC
Fax: (729) 955-7443 CEO: Aaron Levitt
Primary SIC: 2834
A multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

Stock Price Data as of close 10/05/01:
Latest Close: 37.00
Current Dividend Rate: .00
52 Week High: 49.38
Yield: .0%
52 Week Low: 8.03
Beta: .53
5 Year High: 49.38
Liquidity Ratio: 5848.7
5 Year Low: 1.88
Market Value (000): 999000

  
Current Statistics & Growth:
Latest 12 Mos. EPS Change: 100.0%
Total Return Last 12 Months: 205.2%
5-Yr Revenue Growth Rate: 15.93%
Total Return Last 3 Years: 1380.0%
5-Yr EPS Growth Rate: 53.78%
Total Return Last 5 Years: 920.7%
5-Yr Dividend Growth Rate: NC
 
No. Institutions Holding Shares: 108
Shares Held by Institutions: 50.8%

Back